2017
DOI: 10.1016/j.ebiom.2017.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Cutaneous Cannabinoid Signaling in Inflammation - A “High”-way to Heal?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2

Relationship

3
5

Authors

Journals

citations
Cited by 26 publications
(25 citation statements)
references
References 9 publications
0
25
0
Order By: Relevance
“…(Kovács et al, 2016;Tó th et al, 2011;Zouboulis et al, 2008Zouboulis et al, , 2014. Furthermore, we have previously shown that, besides the aforementioned regulators, human SGs are also important players in the endocannabinoid system (ECS) of the skin (Dobrosi et al, 2008;Oláh and Bíró , 2017).…”
Section: Introductionmentioning
confidence: 99%
“…(Kovács et al, 2016;Tó th et al, 2011;Zouboulis et al, 2008Zouboulis et al, , 2014. Furthermore, we have previously shown that, besides the aforementioned regulators, human SGs are also important players in the endocannabinoid system (ECS) of the skin (Dobrosi et al, 2008;Oláh and Bíró , 2017).…”
Section: Introductionmentioning
confidence: 99%
“…These processes are part of the repair mechanism for the skin barrier after experimental disruption as well as in acute contact dermatitis . The known anti‐inflammatory effects of ECs seem to be of special importance . In keratinocytes, FAAH was upregulated following treatment with inflammatory stimuli .…”
Section: Discussionmentioning
confidence: 99%
“…The latter two compounds are thought to activate both CB receptors in keratinocytes by elevating extracellular AEA concentration. Moreover, FAAH inhibition by WOBE440 will increase intracellular AEA concentration as a first step and at the same time decrease the concentration of the pro‐inflammatory AEA degradation product arachidonic acid (AA) in the cell . Since the molecular target of WOL067‐531 has not been identified to date, the compound might interfere with intracellular endocannabinoid signalling as well.…”
Section: Introductionmentioning
confidence: 99%
“…25 The endocannabinoid system consists of at least 2 receptors coupled through G-protein inhibition: cannabinoid receptor 1 (CB 1 ) and cannabinoid receptor 2 (CB 2 ). [26][27][28][29][30] Other receptors sensitive to cannabinoids include vanilloid receptor 1 (TRPV1), 31,32 adenosine receptors, 33,34 5-hydroxytryptamine (5-HT 1A ), 35,36 and G-protein coupled receptors. 37 The CB 1 receptors are most abundant within the central nervous system, located primarily on the axon and synaptic terminals on the neurons, 38 while the CB 2 receptors are much more concentrated within the peripheral nervous system, such as the immune system.…”
Section: The Endocannabinoid Systemmentioning
confidence: 99%